share_log

恒瑞医药:硅谷银行事件对公司境外研发活动及其他运营活动不产生任何负面影响

Hengrui Pharmaceutical: The Silicon Valley Bank incident did not have any negative impact on the company's overseas R&D activities and other operating activities

Breakings ·  Mar 30, 2023 14:07
Hengrui Pharmaceutical said on an interactive platform on March 30 that the company only has extremely small deposits at Silicon Valley banks, and the US Federal Deposit Insurance Corporation (FDIC) provides full coverage for the company's deposits in Silicon Valley banks. The Silicon Valley Bank incident did not have any negative impact on the company's overseas R&D activities and other operating activities.

The translation is provided by third-party software.


The above content is for informational or educational purposes only and does not constitute any investment advice related to Futu. Although we strive to ensure the truthfulness, accuracy, and originality of all such content, we cannot guarantee it.
    Write a comment